Patent details
EP4247833 Title: SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS
Basic Information
- Publication number:
- EP4247833
- PCT Application Number:
- EP2021082323
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP218155000
- PCT Publication Number:
- WO2022106629
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS
- French Title of Invention:
- SYNTHÈSE DE L'ANTIGÈNE MEMBRANAIRE SPÉCIFIQUE DE LA PROSTATE (PSMA) LIGAND
- German Title of Invention:
- SYNTHESE VON LIGANDEN DES PROSTATASPEZIFISCHEN MEMBRANANTIGENS (PSMA)
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 23/10/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 30/10/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 24/09/2025
- Unitary Effect Registration Date:
- 30/10/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 19/11/2021
- Grant date:
- 24/09/2025
- EP Publication Date:
- 27/09/2023
- PCT Publication Date:
- 27/05/2022
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/09/2025
- EP B1 Publication Date:
- 24/09/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/11/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/09/2025
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
- Name:
- ANDREAE, Fritz
- Address:
- Austria (AT)
Priority
- Priority Number:
- 20208556
- Priority Date:
- 19/11/2020
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- C07K 5/083; C07D 257/02;
Publication
European Patent Bulletin
1
- Issue number:
- 202539
- Publication date:
- 24/09/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202544
- Publication date:
- 29/10/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202548
- Publication date:
- 26/11/2025
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202549
- Publication date:
- 03/12/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|